GoodRx (Foundayo + Zepbound KwikPen) vs Synergy Rx
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
GoodRx (Foundayo + Zepbound KwikPen)
Best for self-pay brand-name Foundayo and Zepbound KwikPen at retail pharmaciesStarting at $149/mo
Synergy Rx
Best for broadest drug catalog in the Lion MD white-label clusterStarting at $199/mo
Side-by-Side Comparison
| Feature | GoodRx (Foundayo + Zepbound KwikPen) | Synergy Rx |
|---|---|---|
| Overall Score | ✓8.4/10 | 7.4/10 |
| Starting Price | ✓$149/mo | $199/mo |
| Editorial Rating | ✓4.2 ★ /5 | 3.7 ★ /5 |
| Features | 6 features | 6 features |
| States Available | ✓50 | 0 |
| Compounded | — | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
GoodRx (Foundayo + Zepbound KwikPen)
Pros
- ✓$149/month self-pay price for FDA-approved brand-name Foundayo (orforglipron) — matches the lowest available discounted cash price at launch and is dramatically cheaper than typical retail brand-GLP-1 pricing
- ✓$299/month self-pay for FDA-approved Zepbound KwikPen — significantly under the typical Lilly cash list price
- ✓Honored at 70,000+ US pharmacies nationwide — by far the largest brick-and-mortar redemption network of any GLP-1 distribution channel we cover
- ✓No telehealth membership fee — you bring your own prescription and present the discount card at the pharmacy counter
- ✓Brand-name FDA-approved medication, not compounded — no compounding-pharmacy quality variability or FDA non-evaluation disclaimer
- ✓Pharmaceutical manufacturer-direct pricing model — Lilly is delivering the discounted cash price directly through GoodRx, not a third-party negotiation
Cons
- ✗Requires a valid prescription — GoodRx is a discount card, not a telehealth provider. You still need a clinician to write the script (your existing PCP, an endocrinologist, or a separate telehealth visit)
- ✗Self-pay only — does not coordinate with insurance benefits or apply toward insurance deductibles
- ✗Pricing applies only to the lowest Foundayo dose at the headline number; higher doses may carry different pricing not disclosed in the launch
- ✗Does not include compounded GLP-1s — if you want compounded semaglutide or tirzepatide, this is not the channel
- ✗GoodRx is publicly traded (NASDAQ: GDRX) and pricing is subject to change as Lilly's manufacturer-sponsored coupon program evolves
Synergy Rx
Pros
- ✓Broad drug catalog: compounded sema/tirz in both injection and oral dissolving tablet formats, plus brand-name Ozempic, Wegovy, and Mounjaro
- ✓Claims 50,000+ patients per homepage as of late 2025
- ✓All 50 US states subject to state telehealth regulations
- ✓Same named medical team as Breeze Meds and Care Bare Rx (Dr. Carr and Dr. Tenbrink via Lion MD)
- ✓Four named 503A pharmacy partners (Belmar, Strive, Epiq Scripts, Casa Pharma Rx)
- ✓LegitScript seal displayed in footer
Cons
- ✗Runs on the same Lion MD clinician network and the same 4 compounding pharmacies as Breeze Meds and Care Bare Rx — the three brands are white-labeled storefronts on top of one underlying operation
- ✗Mandatory individual arbitration + class action waiver in ToS (30-day opt-out window from signup)
- ✗Consultation fees are non-refundable and all prescription sales are final per ToS
- ✗Platform explicitly disclaims liability for third-party pharmacy medication quality: 'SynergyRx makes no representations or warranties regarding the efficacy, safety, or outcomes of any medication provided through these third parties'
- ✗State availability is 'subject to each state's telehealth and prescribing regulations' — the full list of active states requires contacting customer service rather than being published
- ✗Do NOT confuse with the unrelated 'Synergy Rx Pharmacy' (San Diego, CA) that issued a voluntary nationwide recall in February 2017 for non-sterile compounded products — that is a different entity in a different state
- ✗Do not visit synergyrx.com — it is a parked domain on Sedo and unrelated to the telehealth brand. The correct domain is synergyrx.co
Our Verdict
GoodRx (Foundayo + Zepbound KwikPen) edges out Synergy Rx with a higher overall score of 8.4/10 and is particularly strong for self-pay brand-name Foundayo and Zepbound KwikPen at retail pharmacies. Synergy Rx remains a solid alternative, especially if you're looking for broadest drug catalog in the Lion MD white-label cluster.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.